Preclinical studies have not identified toxic doses or lethal doses for BPC-157, and researchers reported no teratogenic, genotoxic, anaphylactic, or local toxic effects
FCPS: Will the change from HealthKeepers to BlueChoice impact deductibles already met
Keep sterile technique to reduce infection risk
In addition to funding and conducting research, we are mobilizing our grassroot network advocates to increase the funding for cancer research
Experimental and computational studies on newly synthesized resveratrol derivative: A new method for cancer chemoprevention and therapeutics
After being put on the full dose (2.5mg), she experienced nausea but persevered and found that 2-3 hours after taking the drug, her brain fog completely disappeared and she could focus and work like before